Panbela regains compliance with nasdaq listing standards for bid price and publicly held shares requirements

Minneapolis, feb. 15, 2024 (globe newswire) -- panbela therapeutics, inc. (nasdaq: pbla), (“panbela”), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced that, has regained compliance with applicable listing standards of the nasdaq stock market (“nasdaq”) for bid price and publicly held shares.
PBLA Ratings Summary
PBLA Quant Ranking